Skip to main content
Caplight Logo









Guangzhou Sino-Israel Bio-Industry Investment Fund

Guangzhou Sino-Israel Bio-Industry Investment Fund

Guangzhou, Guangdonggibf-bio.com

Overview

A Sino-Israeli investment fund established in 2016, focusing on cross-border investments in innovative biotech, drug development, and life sciences companies from Israel, Europe, and the USA that are in or approaching clinical stages and aspire to establish activities in China. The fund acts as a strategic partner, providing resources and networks for clinical trials, regulatory submissions, and commercialization in China.

Portfolio Companies

6

Investments

Guangzhou Sino-Israel Bio-Industry Investment Fund investments
CompanyDateStageLead
Orvida Pharma Ltd.Sep 2026VC RoundCo-investor
BioversysSep 2024StrategicLead
Nectin TherapeuticsMay 2024VC RoundCo-investor
BioversysJan 2023Series C Extension-
Orvida Pharma Ltd.Sep 2022VC RoundCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersGuangzhou, Guangdong
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?